首页> 外文期刊>水産增殖 >Protection of Pacific White Shrimp, Litopenaeus vannamei against White Spot Virus Following Administration of N-terminus Truncated Recombinant VP28 Protein Expressed in Gram-positive Bacteria, Brevibacillus choshinensis
【24h】

Protection of Pacific White Shrimp, Litopenaeus vannamei against White Spot Virus Following Administration of N-terminus Truncated Recombinant VP28 Protein Expressed in Gram-positive Bacteria, Brevibacillus choshinensis

机译:给予南美白对虾南美白对虾病毒后,经革兰氏阳性细菌短小芽孢杆菌表达的N-末端截短的重组VP28蛋白给予抗白斑病毒

获取原文
获取原文并翻译 | 示例
       

摘要

To increase survival of different commercially important shrimp species against white spot virus disease (WSVD), a number of combinations using different recombinant VP28 protein forms expressed in Gram-negative or -positive bacteria have been tested.Here, we explored yet another combination to maximize utilization of VP28 specific to Pacific white shrimp, Litopenaeus vannamei to protect it against WSV. Large amounts of N- and an N+C-terminus-deleted recombinant VP28 (rN-VP28 and rNC-VP28) were produced in large amounts in a Gram-positive bacterium, Brevibacillus choshinensis and then administered to the shrimp by either oral feeding or intramuscular injection. Feeding rN-VP28 (50 mu g day~(-1) for 7 days), but not rNC-VP28, provided each shrimp significant protection against WSV. Furthermore, we showed that both oral delivery and intramuscular injection of rN-VP28 were effective for Pacific white shrimp.
机译:为了增加商业上重要的虾品种对白斑病毒病(WSVD)的存活率,已经测试了多种使用革兰氏阴性或阳性细菌中表达的不同重组VP28蛋白形式的组合。在这里,我们探索了另一种组合以最大化利用太平洋白对虾凡纳滨对虾专用的VP28保护其免受WSV侵害。在革兰氏阳性细菌短小芽孢杆菌中大量生产了N-和N + C末端缺失的重组VP28(rN-VP28和rNC-VP28),然后通过口服喂食或肌肉注射。饲喂rN-VP28(每天50μg〜(-1)7天)而不是rNC-VP28,为每只虾提供了显着的抗WSV的保护。此外,我们显示口服递送和肌肉内注射rN-VP28均对太平洋白虾有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号